Clinical Trials Directory

Trials / Sponsors / EVIVE Biotechnology

EVIVE Biotechnology

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnStudy of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) Pneumonia
COVID-19 Pneumonia
Phase 22022-04-08
TerminatedStudy of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19
Covid19
Phase 22021-01-26
UnknownStudy of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
Phase 12019-09-15
CompletedStudy to Compare the Efficacy and Safety of F-627 and GRAN®
Breast Cancer, Neutropenia
Phase 32018-04-12
CompletedNeulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Breast Cancer, Neutropenia
Phase 32018-04-12
CompletedPlacebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Breast Cancer, Neutropenia
Phase 32016-08-01
CompletedStudy of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD
Acute Graft vs Host Disease
Phase 1 / Phase 22016-05-12
CompletedA Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.
Neutropenia
Phase 22014-07-03
CompletedA Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Neutropenia
Phase 1 / Phase 22014-02-25
CompletedStudy of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Neutropenia, Breast Cancer
Phase 12012-12-01
CompletedDose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Breast Cancer, Neutropenia
Phase 22012-06-01